Omicron (B.1.1.529 variant of SARS‐CoV‐2); an emerging threat: Current global scenario-Reference-Cited by-同舟云学术

Omicron (B.1.1.529 variant of SARS‐CoV‐2); an emerging threat: Current global scenario

Published:2022-01-05 Issue: Volume: Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Mohapatra Ranjan K.¹^ORCID,Sarangi Ashish K.²^ORCID,Kandi Venkataramana³^ORCID,Azam Mohammad⁴,Tiwari Ruchi⁵^ORCID,Dhama Kuldeep⁶^ORCID

Affiliation:

1. Department of Chemistry Government College of Engineering Keonjhar Odisha India

2. Department of Chemistry, School of Applied Sciences Centurion University of Technology and Management Odisha India

3. Department of Microbiology Prathima Institute of Medical Sciences Karimnagar Telangana India

4. Department of Chemistry, College of Science King Saud University Riyadh Saudi Arabia

5. Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences Uttar Pradesh Pandit Deen Dayal Upadhyaya Pashu Chikitsa Vigyan Vishwavidyalaya Evam Go Anusandhan Sansthan (DUVASU) Mathura India

6. Division of Pathology ICAR‐Indian Veterinary Research Institute Bareilly India

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27561

Reference49 articles.

1. Coronavirus Disease 2019–COVID-19

2. Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS-CoV-2 main protease (Mpro): DFT, QSAR, molecular docking, and in silico toxicity analysis

3. The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy

4. WHO. WHO Coronavirus (COVID‐19) Dashboard. WHO COVID‐19 Dashboard—Up to date data on pandemic; 2021. Accessed December 18 2021. https://covid19.who.int/?gclid=CjwKCAiA65iBBhB-EiwAW253W0GZ9U6TBkdh4YsVuarVQDugzsyLRuZF-ctQMSaXK8Lcz9kZ14J9kRoC7uAQAvD_BwE

5. CDC. SARS‐CoV‐2 Variant Classifications and Definitions. Accessed December 1 2021.https://www.cdc.gov/

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-strain dynamics of COVID-19 variants in India: Modeling, analysis, and implications for pandemic control;Gene;2024-10

2. Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID®) with Concomitant Medications in Real-World Clinical Settings;2024-04-18

3. A validated LC-MS/MS method for determination of six Anti-SARS-CoV-2 drugs in plasma and its application for a pharmacokinetic study in rats;Journal of Chromatography B;2024-03

4. Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants;Frontiers in Immunology;2024-02-23

5. Stem Cell Extracellular Vesicles as Anti-SARS-CoV-2 Immunomodulatory Therapeutics: A Systematic Review of Clinical and Preclinical Studies;Stem Cell Reviews and Reports;2024-02-23